Join Now

Category Archives: BioUtah News

PolarityTE Reports Second Quarter Financial Results

By Natalie Themm | Published August 12, 2021

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials, today provided a business update and reported financial results for the second quarter ended June 30, 2021.

| Leave a comment

Cytiva acquires Intermountain Life Sciences

By Natalie Themm | Published August 12, 2021

Global life sciences leader Cytiva has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Cytiva will use Intermountain’s manufacturing site in Utah to rapidly boost its liquid cell culture production by millions of liters. Hiring is ongoing to rapidly increase output.

| Leave a comment

Jackson Hospital Continues to Lead by Adding New Non-Invasive Ventilation (NIV) Products; ReddyPort™ Elbow and NIV Maintenance for Oral Care

By admin | Published August 5, 2021

ReddyPort, a medical technology company focused on bringing new non-invasive ventilation (NIV) products into market

| Leave a comment

ELITechGroup received the CE mark for Saliva on SARS-CoV-2 ELITe MGB® Kit

By admin | Published August 5, 2021

ELITechGroup is pleased to announce the CE mark for use of saliva on SARS-CoV-2 ELITe MGB® Kit.

| Leave a comment

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2021

By Natalie Themm | Published August 5, 2021

The second calendar quarter (2Q) of 2021 financial results were dramatically different from 2Q 2020 because 2Q 2020 results were the low point of Utah Medical Products, Inc.’s (Nasdaq: UTMD) performance during the COVID-19 pandemic, during a time when there were restrictions on so-called nonessential medical procedures. Therefore, UTMD management reports quarterly income statement results compared to the same periods not only in 2021 compared to 2020, but also compared to 2019. The Company’s stated objective in 2021 has been to try to fully recover back to its 2019 financial performance. Please see the income statements for all three years on the last page. 

Also posted in Press Releases | | Tagged , | Leave a comment

CenExel Clinical Research Acquires ForCare Clinical Research

By Natalie Themm | Published August 5, 2021

CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of ForCare Clinical Research (“CenExel FCR”), a Tampa-based clinical research organization with Principal Investigators who have more than 40 years of combined research experience. CenExel FCR conducts Phase I through Phase IV studies in both chronic and acute conditions, primarily in Dermatology

Also posted in Press Releases | | Tagged , | Leave a comment

BIOMERICS ANNOUNCES ACQUISITION OF BERG MANUFACTURING INC. & KNIGHT MACHINING LLC.

By Natalie Themm | Published August 5, 2021

Biomerics LLC, a leading mid-market contract manufacturer for the interventional medical device market, announced it has acquired a majority interest in Berg Manufacturing Inc. Berg Manufacturing, based in Santa Clara, California, is an industry leader in Swiss micromachining for the advanced robotic surgery, endoscope, and interventional catheter markets.

Also posted in Press Releases | | Tagged , , | Leave a comment

Myriad Genetics Expands Access to Genetic Testing with Launch of First Polygenic Breast Cancer Risk Assessment Score Validated for Women of All Ancestries

By Natalie Themm | Published August 3, 2021

Advancing its mission to expand access to genetic testing, Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today launched a new version of its market-leading MyRisk Hereditary Cancer Test. For the first time, women of all ancestries can now receive a personalized polygenic breast cancer risk assessment together with the market’s most accurate hereditary cancer test.

Also posted in Press Releases | | Tagged | Leave a comment

Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans

By admin | Published August 3, 2021

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced financial results for its second quarter ended June 30, 2021 and provided an update on recent business performance and strategic transformation plans.

| Tagged | Leave a comment

SkinTE® Met Primary and Secondary Endpoints in Final Analysis from Diabetic Foot Ulcer Trial

By Denise Bell | Published July 29, 2021

PolarityTE on July 28 announced final data from a multi-center randomized controlled trial evaluating treatment of Diabetic Foot Ulcers (DFU) with its investigational product SkinTE®. The trial met the primary endpoint of wound closure at 12 weeks and secondary endpoint of Percent Area Reduction (PAR) assessed at 4, 6, 8, 10, and 12 weeks. Nikolai […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

PolarityTE Receives Notice of Allowance for Chinese Patent

By Denise Bell | Published July 29, 2021

PolarityTE recently announced that the China National Intellectual Property Administration (CNIPA) issued a Notification of Allowance for Chinese Patent Application No. 201580075326.3. The allowed claims relate to skin-regenerative compositions utilizing PolarityTE’s minimally polarized functional unit (MPFU) technology as well as methods of making a skin-regenerative composition utilizing the MPFU technology. This most recent allowance further […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

PolarityTE Submits Investigational New Drug Application for SkinTE®

By Denise Bell | Published July 29, 2021

PolarityTE on Monday announced the submission of an investigational new drug application (IND) to the FDA seeking authorization to commence a clinical trial to evaluate its SkinTE product for the proposed indication of treatment of chronic cutaneous ulcers. SkinTE is PolarityTE’s human cellular and tissue-based product derived from a patient’s own skin. David Seaburg, Chief Executive […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members